CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows from operating activities:
Net income (loss)	$ 11,080,913	$ 1,491,651
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	(11,850,663)	(2,619,630)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	(9,044)	6,000
(Decrease) Increase in accounts payable affiliates	(2,345,707)	(3,839,107)
Net cash (used in) provided by operating activities	(3,124,501)	(4,961,086)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	11,850,561	2,580,529
Net cash provided by investing activities	11,850,561	2,580,529
Cash flows from financing activities:
Distributions	0	(310,963)
Net cash used in financing activities	0	(310,963)
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	8,726,060	(2,691,520)
Cash and cash equivalents, beginning	22,926,529	27,208,717
Cash and cash equivalents, ending	31,652,589	24,517,197
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	25,000	0
Series Twenty [Member]
Cash flows from operating activities:
Net income (loss)	0	128,707
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	0	(155,337)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	(188,017)
Net cash (used in) provided by operating activities	0	(214,647)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	155,337
Net cash provided by investing activities	0	155,337
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	(59,310)
Cash and cash equivalents, beginning	0	241,987
Cash and cash equivalents, ending	0	182,677
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty One [Member]
Cash flows from operating activities:
Net income (loss)	0	0
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash (used in) provided by operating activities	0	0
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	0
Cash and cash equivalents, beginning	0	0
Cash and cash equivalents, ending	0	0
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty Two [Member]
Cash flows from operating activities:
Net income (loss)	0	(32,092)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	(12,148)
Net cash (used in) provided by operating activities	0	(44,240)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	(44,240)
Cash and cash equivalents, beginning	0	221,864
Cash and cash equivalents, ending	0	177,624
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty Three [Member]
Cash flows from operating activities:
Net income (loss)	0	(25,440)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	(238,888)
Net cash (used in) provided by operating activities	0	(264,328)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	(264,328)
Cash and cash equivalents, beginning	0	446,136
Cash and cash equivalents, ending	0	181,808
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty Four [Member]
Cash flows from operating activities:
Net income (loss)	(39,827)	(41,674)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	(5,000)
(Decrease) Increase in accounts payable affiliates	0	0
Net cash (used in) provided by operating activities	(39,827)	(46,674)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(39,827)	(46,674)
Cash and cash equivalents, beginning	402,018	453,512
Cash and cash equivalents, ending	362,191	406,838
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty Five [Member]
Cash flows from operating activities:
Net income (loss)	0	0
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash (used in) provided by operating activities	0	0
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	0
Cash and cash equivalents, beginning	0	0
Cash and cash equivalents, ending	0	0
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty Six [Member]
Cash flows from operating activities:
Net income (loss)	(56,168)	(47,551)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	0	(10,500)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash (used in) provided by operating activities	(56,168)	(58,051)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	10,500
Net cash provided by investing activities	0	10,500
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(56,168)	(47,551)
Cash and cash equivalents, beginning	554,439	642,258
Cash and cash equivalents, ending	498,271	594,707
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty Seven [Member]
Cash flows from operating activities:
Net income (loss)	800,839	(9,396)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	(776,922)	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash (used in) provided by operating activities	23,917	(9,396)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	776,922	0
Net cash provided by investing activities	776,922	0
Cash flows from financing activities:
Distributions	0	(310,963)
Net cash used in financing activities	0	(310,963)
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	800,839	(320,359)
Cash and cash equivalents, beginning	6,500,234	6,799,933
Cash and cash equivalents, ending	7,301,073	6,479,574
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty Eight [Member]
Cash flows from operating activities:
Net income (loss)	(30,463)	(26,522)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	(7,100)	(8,500)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash (used in) provided by operating activities	(37,563)	(35,022)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	7,100	8,500
Net cash provided by investing activities	7,100	8,500
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(30,463)	(26,522)
Cash and cash equivalents, beginning	690,605	742,564
Cash and cash equivalents, ending	660,142	716,042
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Twenty Nine [Member]
Cash flows from operating activities:
Net income (loss)	(42,141)	76,582
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	0	(123,094)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	14,520	(497,247)
Net cash (used in) provided by operating activities	(27,621)	(543,759)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	122,994
Net cash provided by investing activities	0	122,994
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(27,621)	(420,765)
Cash and cash equivalents, beginning	196,944	622,414
Cash and cash equivalents, ending	169,323	201,649
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty [Member]
Cash flows from operating activities:
Net income (loss)	0	6,824
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	0	(41,555)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	3,000
(Decrease) Increase in accounts payable affiliates	0	(166,736)
Net cash (used in) provided by operating activities	0	(198,467)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	25,006
Net cash provided by investing activities	0	25,006
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	(173,461)
Cash and cash equivalents, beginning	0	453,433
Cash and cash equivalents, ending	0	279,972
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty One [Member]
Cash flows from operating activities:
Net income (loss)	654,911	16,103
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	(618,900)	(69,452)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	2,500
(Decrease) Increase in accounts payable affiliates	0	0
Net cash (used in) provided by operating activities	36,011	(50,849)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	618,900	47,000
Net cash provided by investing activities	618,900	47,000
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	654,911	(3,849)
Cash and cash equivalents, beginning	1,953,570	1,971,680
Cash and cash equivalents, ending	2,608,481	1,967,831
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	25,000	0
Series Thirty Two [Member]
Cash flows from operating activities:
Net income (loss)	(51,389)	420,871
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	0	(487,880)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	(11,620)	(745,999)
Net cash (used in) provided by operating activities	(63,009)	(813,008)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	487,880
Net cash provided by investing activities	0	487,880
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(63,009)	(325,128)
Cash and cash equivalents, beginning	272,226	563,697
Cash and cash equivalents, ending	209,217	238,569
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty Three [Member]
Cash flows from operating activities:
Net income (loss)	1,423,100	(40,690)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	(1,442,632)	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	(1,099,287)	(180,304)
Net cash (used in) provided by operating activities	(1,118,819)	(220,994)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	1,442,632	0
Net cash provided by investing activities	1,442,632	0
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	323,813	(220,994)
Cash and cash equivalents, beginning	236,612	452,033
Cash and cash equivalents, ending	560,425	231,039
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty Four [Member]
Cash flows from operating activities:
Net income (loss)	216,071	(39,631)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	(257,500)	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	23,861	(125,268)
Net cash (used in) provided by operating activities	(17,568)	(164,899)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	257,500	0
Net cash provided by investing activities	257,500	0
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	239,932	(164,899)
Cash and cash equivalents, beginning	178,285	394,837
Cash and cash equivalents, ending	418,217	229,938
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty Five [Member]
Cash flows from operating activities:
Net income (loss)	132,796	(20,322)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	(141,000)	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash (used in) provided by operating activities	(8,204)	(20,322)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	141,000	0
Net cash provided by investing activities	141,000	0
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	132,796	(20,322)
Cash and cash equivalents, beginning	4,395,774	4,428,306
Cash and cash equivalents, ending	4,528,570	4,407,984
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty Six [Member]
Cash flows from operating activities:
Net income (loss)	465,273	182,394
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	(476,325)	(243,163)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	(4,900)	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash (used in) provided by operating activities	(15,952)	(60,769)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	476,325	243,163
Net cash provided by investing activities	476,325	243,163
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	460,373	182,394
Cash and cash equivalents, beginning	2,541,359	2,106,050
Cash and cash equivalents, ending	3,001,732	2,288,444
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty Seven [Member]
Cash flows from operating activities:
Net income (loss)	0	1,014,258
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	0	(1,020,649)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	(513,149)
Net cash (used in) provided by operating activities	0	(519,540)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	1,020,649
Net cash provided by investing activities	0	1,020,649
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	501,109
Cash and cash equivalents, beginning	0	517,887
Cash and cash equivalents, ending	0	1,018,996
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty Eight [Member]
Cash flows from operating activities:
Net income (loss)	1,442,036	8,500
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	(1,463,974)	(7,000)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	(18,234)
Net cash (used in) provided by operating activities	(21,938)	(16,734)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	1,463,974	7,000
Net cash provided by investing activities	1,463,974	7,000
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	1,442,036	(9,734)
Cash and cash equivalents, beginning	1,499,106	1,492,145
Cash and cash equivalents, ending	2,941,142	1,482,411
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Thirty Nine [Member]
Cash flows from operating activities:
Net income (loss)	0	0
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash (used in) provided by operating activities	0	0
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	0	0
Cash and cash equivalents, beginning	0	0
Cash and cash equivalents, ending	0	0
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Forty [Member]
Cash flows from operating activities:
Net income (loss)	2,500,441	(24,459)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	(2,554,005)	(44,500)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	(4,144)	5,500
(Decrease) Increase in accounts payable affiliates	(1,148,217)	(171,812)
Net cash (used in) provided by operating activities	(1,205,925)	(235,271)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	2,553,903	44,500
Net cash provided by investing activities	2,553,903	44,500
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	1,347,978	(190,771)
Cash and cash equivalents, beginning	193,344	431,341
Cash and cash equivalents, ending	1,541,322	240,570
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Forty One [Member]
Cash flows from operating activities:
Net income (loss)	(33,697)	(38,575)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	0	(14,000)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	68,154	(448,150)
Net cash (used in) provided by operating activities	34,457	(500,725)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	14,000
Net cash provided by investing activities	0	14,000
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	34,457	(486,725)
Cash and cash equivalents, beginning	246,214	741,152
Cash and cash equivalents, ending	280,671	254,427
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Forty Two [Member]
Cash flows from operating activities:
Net income (loss)	(58,859)	(8,464)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	0	(42,500)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	0	0
Net cash (used in) provided by operating activities	(58,859)	(50,964)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	42,500
Net cash provided by investing activities	0	42,500
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(58,859)	(8,464)
Cash and cash equivalents, beginning	1,300,483	1,327,017
Cash and cash equivalents, ending	1,241,624	1,318,553
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Forty Three [Member]
Cash flows from operating activities:
Net income (loss)	1,186,830	(45,306)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	(1,255,582)	(9,000)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	(168,259)	(475,580)
Net cash (used in) provided by operating activities	(237,011)	(529,886)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	1,255,582	9,000
Net cash provided by investing activities	1,255,582	9,000
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	1,018,571	(520,886)
Cash and cash equivalents, beginning	414,540	854,364
Cash and cash equivalents, ending	1,433,111	333,478
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Forty Four [Member]
Cash flows from operating activities:
Net income (loss)	2,763,147	(100,237)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	(2,856,723)	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	(132,745)	122,738
Net cash (used in) provided by operating activities	(226,321)	22,501
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	2,856,723	0
Net cash provided by investing activities	2,856,723	0
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	2,630,402	22,501
Cash and cash equivalents, beginning	113,020	84,006
Cash and cash equivalents, ending	2,743,422	106,507
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Forty Five [Member]
Cash flows from operating activities:
Net income (loss)	(117,120)	225,230
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	0	(342,500)
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	3,288	(104,911)
Net cash (used in) provided by operating activities	(113,832)	(222,181)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	342,500
Net cash provided by investing activities	0	342,500
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(113,832)	120,319
Cash and cash equivalents, beginning	916,581	753,702
Cash and cash equivalents, ending	802,749	874,021
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	0	0
Series Forty Six [Member]
Cash flows from operating activities:
Net income (loss)	(74,867)	(87,459)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities
Gain on disposition of Operating Partnerships	0	0
Changes in assets and liabilities
(Decrease) Increase in accounts payable and accrued expenses	0	0
(Decrease) Increase in accounts payable affiliates	104,598	(75,402)
Net cash (used in) provided by operating activities	29,731	(162,861)
Cash flows from investing activities:
Proceeds from the disposition of Operating Partnerships	0	0
Net cash provided by investing activities	0	0
Cash flows from financing activities:
Distributions	0	0
Net cash used in financing activities	0	0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	29,731	(162,861)
Cash and cash equivalents, beginning	321,175	466,399
Cash and cash equivalents, ending	350,906	303,538
Supplemental schedule of noncash investing and financing activities:
The Fund applied notes receivable and advances to its capital contribution obligation to Operating Partnerships.	$ 0	$ 0